{"name":"Biomedica Management Corporation","slug":"biomedica-management-corporation","ticker":"","exchange":"","domain":"","description":"Biomedica Management Corporation is a specialty pharmaceutical company focused on developing and commercializing innovative medical treatments. The company's pipeline includes one drug in Phase 1 development, ClotFoam, which is designed to address unmet needs in hemostasis. Limited financial and operational data are available.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"ClotFoam","genericName":"ClotFoam","slug":"clotfoam","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"ClotFoam","genericName":"ClotFoam","slug":"clotfoam","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxNSkRSenZaYWtJcjRDMU85dlRobkNTaUNGekNqTWlMa1RCQ2ZOQzk4aEsta2NiYmk1eE5qYjZoUDYzNGx1RV90RzBCblo3VWFlQUVqTkItVm9scVB2VWZUZnE4MVRta3ZUVXFzbFlBNmVpS1FhQXNTb2pQY1QtVHYxUG9oM3o3MDR3eC1vN3AyUWEwTXJWdlZ4bHBGSlMzcjViUFk4eWwwSWZjRnN5YXBIY28zbw?oc=5","date":"2026-02-25","type":"pipeline","source":"Sharecast.com","summary":"EQT not planning to bid for Oxford Biomedica - Sharecast.com","headline":"EQT not planning to bid for Oxford Biomedica","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxQUzJDQTRnQ2pOU0JoUUJRT2YxYm9Qc3hIaFY4WktwR09HeDFLaVRCQ0dRRzF4RHJ1RnN3cTFVUFUyVzVjVFJjZmpuS3VCbTlpQ1RTQi1OcnhPWFZ1ZUJWTHpDN1hwbW51UGlBdUlFU3NrYzdXSWRob1Y0Q3F1QUs3c3dNcl9sNU16amtjT2lB?oc=5","date":"2026-02-05","type":"pipeline","source":"The Motley Fool","summary":"Best Biotech Stocks of 2026 and How to Invest in Them - The Motley Fool","headline":"Best Biotech Stocks of 2026 and How to Invest in Them","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxOdnZ0blhpTXo0dkdFNEp6RDBtaWo2S2lOdmhYeDJxWGJpT09kRnRDc1BQVkdJaVJ4NWtPWUlGT183T2VtWVJYRC1KMXJzSWFMMjdPLUl6WGhTdnZpTVpFeVBKMWZsMEFHNlVZbG95VTVWcUxrZzFXVHFmY1FweURQQnZSeXNQcXM0SW01MFpYU0FPSFR0bVVXT1BOM1BjZm96WmgxNGNDQlFvR2t5aDJrNTNPWGtDdVVJ?oc=5","date":"2026-01-14","type":"pipeline","source":"The Times","summary":"Oxford Biomedica in talks over EQT takeover bid - The Times","headline":"Oxford Biomedica in talks over EQT takeover bid","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTFAyMnRkdkdwUWJEX2d2Q1I0SEU4Sl9wQnVHTTlJRlJRYm9lbzFKQXhzQUk5X3ZNZDFiRUpfV0hpd2wxRGNXd2dkQzlCcHFNX2x6MEpzbVRENzR5c0lINFpz?oc=5","date":"2025-10-16","type":"pipeline","source":"Nature","summary":"A new kind of gateway to China’s biomedical boom - Nature","headline":"A new kind of gateway to China’s biomedical boom","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxObXBvdG9BdWlnbElnbm94R3U2enQyME85ZXZlT0t4b2wyeUd4dHV4OWpvWThFcjU3OF9YWFVYYWdheTJuRy1PNVMxMjdIN1p0SUlIMkd4cU5vRmczclV6N20wdjc0WGVMLWdxZzI2NnRrS3pta1VZZHI3dWY5QkgyQzItYzhhUExyQW93bnVMT1FIemZDcXF1ZDA3NmF2SGExV2RQMUVFdmQ?oc=5","date":"2025-10-14","type":"pipeline","source":"PR Newswire","summary":"ABK Biomedical Raises US$35M in Series D Financing - PR Newswire","headline":"ABK Biomedical Raises US$35M in Series D Financing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxQbC1HNzhIbTFOeEtOaHlxVnpBX2pBcUE2WktRRWpaMDZVRE1pejFMOEk4aFBqQ3IxUXRUWEI0M1htd0hHX3JhZ1BJZTNta2s4em9RU2J6dXJzT1A5eF90YWlhbm5yZy1nejJRVFU3RUQtM3RQVFRfa3VxbF9pQTE0VEtXRUtlNlJBbElJSFB3TXM3bmtmanFEdDEyUjl6U0dGdzZRSDNHU0FPcXJaTVk5b29aRTJkeWNtNHozMUs2dWVWTDhF?oc=5","date":"2025-09-01","type":"pipeline","source":"BioSpectrum India","summary":"How Waste Management Strategies Can Transform Indian Pharma Manufacturing - BioSpectrum India","headline":"How Waste Management Strategies Can Transform Indian Pharma Manufacturing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizAFBVV95cUxPYWE1ZDN0eE5PTkwtUy1HdXU5b0xkXzlhMjBFRnZZQjA1R0hjeEtaQVM2QUd5WndmOUNWVzBTWWFFaFJKamlibWgyaDBWVXlsNzdsbnJJVlMzdzlCX3FZUmxaczE5bWtqQ2toNFQ3T0VpUkJuaHREXzV0dFZMVTJZSmVmeGM0OHRHZzlOMTlMZHZ5VThYalIxSXdPSkMxNVd4UlU4SnhLbFNwWUhRLXU2RWd3YmwtU2FKZkJWRGFIc0VodUlhWWFmUFB0WWk?oc=5","date":"2025-08-28","type":"pipeline","source":"studlife.com","summary":"WashU and pharmaceutical company MilliporeSigma agree to collaborate on biomedical research - studlife.com","headline":"WashU and pharmaceutical company MilliporeSigma agree to collaborate on biomedical research","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2AFBVV95cUxPWnU4eHlVRnBDR09vby1sSHp2a2l2c2hnM0R1VkNEVnpSSVNZMGcwVFRQTDBfaXNWQU5ncG90NGhWaU9CaldKZldhZVV6MTVpU1pNOVFuZmNSWUdtRDFQMW1FMWZSLXF1XzNJOVBsWEdFUXdXQzhaSC1TN3d2dVoxLWNvYkh4VEVuRzVzTkViVlFTMjhDV0JDWFhvLWJocGpFS3ZIaW5FRmtDbXpUaE5YZUd6cG9vT1haVmZubERINGROQmJoc25ILUdnX0d4STFfRm90WGNQbDI?oc=5","date":"2025-08-13","type":"pipeline","source":"Contract Pharma","summary":"Phosphorex, NOF Corporation, NeoSome Life Sciences, NIS, and Envol Biomedical Form the LNP Alliance - Contract Pharma","headline":"Phosphorex, NOF Corporation, NeoSome Life Sciences, NIS, and Envol Biomedical Form the LNP Alliance","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgJBVV95cUxOc2h4V284amFXUHU1VmtCN1NBbjh0WFBJLWZCTDd1LW5NaFBoWHpGSWZQZGFJWENuQl9Ta1FCajd2ZktyUXFfMmJKNWtZRU1UdnVLczhUeUs1eFJvVjJ5MmtGeFd5UHI3Nk54dFVpVk1wM1BFMnR0NXVNWXFxSnFxX195ZmptZFFrbk9GQ19zN01rWjIwdlZmZ0QtRHZiY0VMLWlyckVZbUJqZXM3MlpkajRCZ19nd2xCRDEyT1pVX2VpcmY0MUVjUDFEZzZKbTVSc0w4OGpCM0NqcDUtTmRRNUs0TXZ6eGZmUm1jS0FJcThzUjFRZXNzMTRkNFgtTHlsMllxRUxR?oc=5","date":"2025-07-01","type":"pipeline","source":"Business Wire","summary":"Catalio Capital Management Raises Over $400M to Invest in Innovative Healthcare Companies in its Fourth Venture Fund - Business Wire","headline":"Catalio Capital Management Raises Over $400M to Invest in Innovative Healthcare Companies in its Fourth Venture Fund","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxQN2wzNFdHTDNla2x0M19VRTh3U3BPdzBjZGZIcU1XeWxlbnBMRzd4Q1N3U2dzcmNjS0tJMlFOa1N1YkxEWElaZWw4aFNLS2Y3MTY1LWdmUVdSaXdKdmc4cDY3WHNJSzFiSzNHbUx3SkpxUWtyVWYtMDQyUDJqSHVlYjcxb1VrcmVVc3FPXzRrZDc3Rmt0Wkp6cmFsSkwwMGl5U3UzS1k3d1hwZnBU?oc=5","date":"2025-06-27","type":"pipeline","source":"statnews.com","summary":"Proposed cuts could have ‘catastrophic effect,’ 110 biomedical, health sciences industry leaders tell Congress - statnews.com","headline":"Proposed cuts could have ‘catastrophic effect,’ 110 biomedical, health sciences industry leaders tell Congress","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxOS2NOcUJYX0RTMGNDNEM2a182YXVxZFRodVNrUVNPYmdmY3NfXzlLTnpEX1BsWWJCaldnaGVOS3FYNlFod21TZ2tURVZwdlhBbFRLcmlJOGdKYTRLbDYzaDczS2dFd1RxZGZxRXFCM01KWFpXQy1PSmNFNDNBSVBCQ3BDakRPS0RJeVFBdUR2REEwV0JCOEt1WVluRmtyN3pNNy1hcE94WTZpRDlmSlBUbHVwbzg1ZUhIUXc?oc=5","date":"2025-06-23","type":"deal","source":"Stock Titan","summary":"Global Pharma Merger: Dr Ashleys Takes Over NYSE-Listed Impact BioMedical to Fast-Track Drug Patents - Stock Titan","headline":"Global Pharma Merger: Dr Ashleys Takes Over NYSE-Listed Impact BioMedical to Fast-Track Drug Patents","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxQbS1FNm9YN0xMbzYxUllOM0JxM0JMQXlHSE9KZWlseEloT2JYdmEyRjUzN1FwX2dBSkJfQzRyWEYweU5FeHhrVEE1QU9NYUJzU1pHMFNwTjBJM2JvblZ6cDNhcktrNDNlRUpjN3ZJU0l4MmtYaDVrRjZBV3IwZkJxci16MEdfS3RfcGZV?oc=5","date":"2025-04-29","type":"pipeline","source":"Holland & Knight","summary":"Holland & Knight Health Dose: April 29, 2025 - Holland & Knight","headline":"Holland & Knight Health Dose: April 29, 2025 - Holland & Knight","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}